Alaunos Therapeutics, Inc. (TCRT) Financials
TCRT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 19.4 million | 5.5 million |
| 2023-06-30 | 27.9 million | 6.3 million |
| 2023-03-31 | 48.6 million | 19.1 million |
| 2022-12-31 | 64.9 million | 26.4 million |
TCRT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -6.4 million | 726000 |
| 2023-06-30 | -7.1 million | 914000 |
| 2023-03-31 | -9.4 million | 910000 |
| 2022-12-31 | -7.2 million | 877000 |
TCRT Net Income
No data available :(
TCRT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 11.9 million | - | 1.2 million |
| 2023-06-30 | 18.3 million | - | 1.6 million |
| 2023-03-31 | 23.5 million | - | 2.6 million |
| 2022-12-31 | 39.1 million | - | 2.7 million |
TCRT Shares Outstanding
TCRT Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 1000 | 3.7 million | 3.6 million | - |
| 2023-06-30 | 135000 | 5.2 million | 3.0 million | - |
| 2023-03-31 | 61000 | 6.5 million | 3.2 million | - |
| 2022-12-31 | 116000 | 5.6 million | 9.7 million | -6.8 million |
TCRT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 1.1 million |
| 2023-06-30 | 4000 | 1.5 million |
| 2023-03-31 | - | 696000 |
| 2022-12-31 | 11000 | 805000 |
TCRT
Price: $1.37
52 week price:
Earnings Per Share: -33.00 USD
P/E Ratio: -1.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 416200
Market Capitalization: 25.8 million